Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100022/S046

Zilver PTX Drug-Eluting Peripheral Stent

Cook Ireland, Ltd. · Decision date Nov 6, 2026

MEDTECHLEDGER EXPLANATIONP100022/S046

What did the FDA decide?

FDA record P100022/S046 is a 30-Day Notice supplement tied to PMA P100022, so it concerns a manufacturing process change rather than a fresh approval of the stent system. The stated change was approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent.

The source does not describe the equipment itself, the packaging step affected, or any clinical or labeling change. It also does not provide evidence of safety or effectiveness; it only records the packaging-related manufacturing change for this PMA supplement.

FDA approval order statement

approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 6, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100022/S046
Regulatory pathway
PMA supplement
Product code
NIU
Decision code
OK30
Decision date
Nov 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, superficial femoral artery, drug-eluting.

Product code
NIU
FDA device class
3

For the original device and its historical approval scope, see PMA P100022. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100022 · Original PMA

    ZILVER PTX DRUG-ELUTING PERIPHERAL STENT

  2. P100022/S046 received

    Application receipt date recorded by FDA.

  3. P100022/S046 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P100022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100022

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA approvalNov 14, 2012FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook Ireland, Ltd.

Headquarters
Not reported
Brand website
cookmedical.com
FDA applicant address
O' Halloran Rd., National Technology Park, Limerick

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records